Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report

Patients who receive solid organ transplants are at higher risk for developing cancer, which is attributable to chronic immune suppression. Less than 8 cases of metastatic RCC (mRCC) have been reported until now. The aim of this article is to present the case of a 77-year-old male with mRCC of the n...

Descripción completa

Detalles Bibliográficos
Autores principales: Suso-Palau, Daniel, Chavarriaga, Julián, Usubillaga, Francisco, Asprilla, Josué, Micolta, Lina, Urrego, Marcela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036129/
https://www.ncbi.nlm.nih.gov/pubmed/35480854
http://dx.doi.org/10.1016/j.eucr.2022.102082
_version_ 1784693455936552960
author Suso-Palau, Daniel
Chavarriaga, Julián
Usubillaga, Francisco
Asprilla, Josué
Micolta, Lina
Urrego, Marcela
author_facet Suso-Palau, Daniel
Chavarriaga, Julián
Usubillaga, Francisco
Asprilla, Josué
Micolta, Lina
Urrego, Marcela
author_sort Suso-Palau, Daniel
collection PubMed
description Patients who receive solid organ transplants are at higher risk for developing cancer, which is attributable to chronic immune suppression. Less than 8 cases of metastatic RCC (mRCC) have been reported until now. The aim of this article is to present the case of a 77-year-old male with mRCC of the native kidney and discuss treatment options including targeted therapy, which appears to be the treatment of choice, even in the era of immunotherapy.
format Online
Article
Text
id pubmed-9036129
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90361292022-04-26 Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report Suso-Palau, Daniel Chavarriaga, Julián Usubillaga, Francisco Asprilla, Josué Micolta, Lina Urrego, Marcela Urol Case Rep Oncology Patients who receive solid organ transplants are at higher risk for developing cancer, which is attributable to chronic immune suppression. Less than 8 cases of metastatic RCC (mRCC) have been reported until now. The aim of this article is to present the case of a 77-year-old male with mRCC of the native kidney and discuss treatment options including targeted therapy, which appears to be the treatment of choice, even in the era of immunotherapy. Elsevier 2022-04-11 /pmc/articles/PMC9036129/ /pubmed/35480854 http://dx.doi.org/10.1016/j.eucr.2022.102082 Text en © 2022 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Suso-Palau, Daniel
Chavarriaga, Julián
Usubillaga, Francisco
Asprilla, Josué
Micolta, Lina
Urrego, Marcela
Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_full Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_fullStr Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_full_unstemmed Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_short Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_sort metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: revisiting the era of tyrosine kinase inhibitors – case report
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036129/
https://www.ncbi.nlm.nih.gov/pubmed/35480854
http://dx.doi.org/10.1016/j.eucr.2022.102082
work_keys_str_mv AT susopalaudaniel metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT chavarriagajulian metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT usubillagafrancisco metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT asprillajosue metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT micoltalina metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT urregomarcela metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport

Ejemplares similares